8-KThe WireRoutine
Company Update
Filed Jun 23, 2026 · 10d ago · Accession 0001193125-26-278533
Plain English
Phathom Pharmaceuticals, Inc. announced the completion of patient enrollment in its Phase 2 clinical trial for VOQUEZNA® in adults with eosinophilic esophagitis. Topline results are expected in the fourth quarter 2026.
Filing details
- Ticker
- PHAT
- CIK
- 1783183
- Form type
- 8-K
- Filing date
- Jun 23, 2026
- Report date
- Jun 23, 2026
- Document
- d166684d8k.htm
- Size
- 139 KB